Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

China Cord Blood Corporation (CO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 839,500
  • Shares Outstanding, K 73,000
  • Annual Sales, $ 110,410 K
  • Annual Income, $ 18,330 K
  • 36-Month Beta 0.91
  • Price/Sales 7.74
  • Price/Cash Flow 35.75
  • Price/Book 1.98

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.78 +3.71%
on 09/22/17
14.95 -25.22%
on 08/24/17
-1.13 (-9.18%)
since 08/22/17
3-Month
9.12 +22.59%
on 06/30/17
14.95 -25.22%
on 08/24/17
+1.58 (+16.46%)
since 06/22/17
52-Week
4.27 +161.83%
on 12/16/16
14.95 -25.22%
on 08/24/17
+5.81 (+108.19%)
since 09/22/16

Most Recent Stories

More News
China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017

China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services,...

BACHF : 0.4950 (-1.00%)
CO : 11.18 (-2.78%)
Medical Research Stocks on Investors' Radar -- China Cord Blood, VWR Corp., Quest Diagnostics, and LabCorp

If you want a Stock Review on CO, VWR, DGX, or LH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, August 28, 2017, US markets saw...

VWR : 33.16 (+0.09%)
DGX : 102.11 (+0.55%)
CO : 11.18 (-2.78%)
LH : 155.07 (+0.77%)
China Cord Blood Corporation Announces Adoption of 10b5-1 Sales Plan

China Cord Blood Corporation (NYSE: CO) (the "Company") today announced that Magnum Opus Second (PTC) Limited, an entity holding ordinary shares on behalf of certain directors and members of senior management,...

CO : 11.18 (-2.78%)
Investor Network: China Cord Blood Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 24, 2017 / China Cord Blood Corporation (NYSE: CO) will be discussing their earnings results in their Q1 Earnings Call to be held August 24, 2017 at 8:00 AM Eastern...

CO : 11.18 (-2.78%)
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2018

-- 1Q18 Added 22,523 New Subscribers

CO : 11.18 (-2.78%)
July 26, 2017 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital

The following is an open letter sent July 26, 2017 U.S. time to the Board of Directors of China Cord Blood Corp (NYSE: CO) from Jayhawk Capital.

VRX.TO : 17.30 (-1.42%)
CO : 11.18 (-2.78%)
Featured Company News - Thermo Fisher's Companion Diagnostic Test to Screen Multiple Non-Small Cell Lung Cancer Gets Pre-market Approval from US FDA

Research Desk Line-up: China Cord Blood Post Earnings Coverage

TMO : 188.30 (+0.21%)
CO : 11.18 (-2.78%)
China Cord Blood Corporation achieves better net income of CNY126.2m for fiscal 2017

Cord blood company China Cord Blood Corporation (NYSE:CO) stated on Wednesday that its net income was CNY126.2m for full year of the fiscal year 2017 ended 31 March 2017.

CO : 11.18 (-2.78%)
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2017

Added 20,566 New Subscribers in 4Q17

CO : 11.18 (-2.78%)
China Cord Blood Has Returned 63.4% Since SmarTrend Recommendation (CO)

SmarTrend identified an Uptrend for China Cord Blood (NYSE:CO) on December 14th, 2016 at $5.20. In approximately 6 months, China Cord Blood has returned 63.43% as of today's recent price of $8.49.

CO : 11.18 (-2.78%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly oversold territory. Beware of a trend reversal.

See More

Business Summary

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing and Guangdong). Under the current PRC government regulations, only one licensed cord blood...

See More

Support & Resistance

2nd Resistance Point 11.86
1st Resistance Point 11.52
Last Price 11.18
1st Support Level 10.81
2nd Support Level 10.44

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.